q&a: what are costs and side effects of antibody drug conjugates? - onctalk lung 2023
Published 2 months ago • 17 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
7:29
antibody drug conjugates: what are antibodies? - onctalk lung 2023
-
3:44
bispecific antibodies in lung cancer - onctalk lung 2023
-
6:39
q&a: how do i handle side effects? - targeted therapies in lung cancer 2023
-
3:21
bispecific antibodies: amivantamab - onctalk lung 2023
-
1:37
pros and cons of bispecific antibodies - blood cancer onctalk 2023
-
1:58
the role of antibody drug conjugates in lung cancer care
-
3:36
q&a: financial or location limitations to bispecific antibody treatments? -blood cancer onctalk 2023
-
2:40
identifying individuals at higher risk of breast cancer - the importance of testing 2023
-
12:20
cost of & access to molecularly targeted therapies as barriers to optimal care
-
3:41
q&a: what can patients do to close the biomarker testing gap?-targeted therapies in lung cancer 2023
-
2:37
q&a: what are the platform options for sbrt? - targeted therapies in lung cancer 2023
-
6:43
what factors determine a successful clinical trial? - lung cancer onctalk 2022
-
7:33
q&a: what are the differences in palliative and hospice care?-targeted therapies in lung cancer 2023
-
3:26
q&a: what does lung cancer surgical recovery look like? - onctalk lung 2023
-
2:52
location of disease: can metastatic locations predict success of treatment? - onctalk 2022
-
2:36
q&a: should biomarker testing be performed on patients with scc? - targeted therapies in lung cancer
-
1:55
how do i find clinical trials? - blood cancer onctalk
-
3:30
barriers to biomarker testing: cost and insurance
-
4:57
q&a: is biomarker testing common in early stage nsclc? - targeted therapies in lung cancer 2023